
Dettmar Cramer
Ask VT AI
View News Summary
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a damning report.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a damning report.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Dettmar Cramer
News from Dettmar Cramer
